Debut is an unconventional innovation company, integrating breakthrough biotechnology and brand creation to build businesses that represent the next generation of sustainable wellness. With proprietary screening, testing and cell-free biomanufacturing technology, we unlock novel actives to power global personal care and health brands. Our mission is to set a new standard for big business through our dynamic intrapreneurial model and to create purposeful brands that push humanity forward.

Air Force Research Laboratory

Springtide Ventures

KdT Ventures

Better Ventures

Cantos

FTW Ventures

ACVC Partners

Material Impact Fund

Cultivian Sandbox Ventures

Fine Structure Venture

Humboldt Fund

Business Opportunities for L'Oréal Development

Cavallo Ventures

GS Futures

Debut

Thank you very much to Kelly Kovack and BeautyMatter for publishing my opinion piece on clean beauty titled: “In Beauty, The Opposite of Clean is Not Dirty, It’s Science”.

Unlike clean beauty, which is riddled with cleanwashing claims, there can be no “biotech-washing” with biotech beauty. Biotechnology is underpinned by science, rigorous clinical testing, and manufacturing standards that have pharma-like precision and data credibility. There is zero margin for marketing interpretation or spin.

Moreover, the regulatory landscape will always favor biotech over cultivation or petroleum-based methods because safety, purity, consistency, and quality are hardwired in the way we manufacture ingredients.

We are entering a new era in beauty that has no place for cleanwashing.

Biotechnology is beauty’s new frontier and Debut is leading the next industrial transformation in beauty!

#biotechnology #biotechbeauty #beautyindustry #cleanbeauty #sustainability #beauty #innovation #skincare #cosmetics #futureofbeauty #precisionbeauty #sciencebackedbeauty


Inflammaging is the latest focus in skin aging.

https://lnkd.in/eSmDKSKM

#skincare #agingwell #beautyinnovation 

Meet Naringenin, our biotech cosmetic active superstar.

Thank you Global Cosmetic Industry for the great profile.

https://lnkd.in/egPx6QeC

Thank you WWD and Noor Lobad for the thoughtful piece on our launch - we are so honored to be profiled!

https://lnkd.in/eYi4RE6y

#beautyinnovation #skincare #launch 

Amazon

Font Awesome

nginx

DNSSEC

Amazon S3

Amazon CloudFront

Amazon SSL

Global Privacy Control

AWS Cloudfront Chicago IL Edge

Cookie Consent by Osano

Co-Founder

Gregory Weiss

Founder & Chief Executive Officer

Joshua Britton

Owner

Susan Nesvold

Director - Gene Discovery

Ali Emileh, Ph.D.

Business Management

Christopher Prier

Director of Research

Erik Holtzapple

Director of PMO and Business Development

Joseph Magbanua

Team Lead, Metabolic Engineering

Angelica Bautista

Lab Manager

Isaac Salas

Consumer Insights Manager

Isabella Mistry

Dan Phillips

Dominique Gagnon

VP/GM, Consumer Brands

Consumer Goods Companies (Top 10K)

Private Greater San Diego Area Companies (Top 10K)

Western US Companies With Less Than $1B in Revenue (Top 10K)

Biotechnology Early Stage Companies With Less Than $500M in Revenue

Debut is an unconventional innovation company that integrates breakthrough biotechnology and brand creation to build businesses that represent the next generation of sustainable wellness. With proprietary screening, testing, and cell-free biomanufacturing technology, we unlock novel activities to power global personal care and health brands. Their mission is to set a new standard for big business through a dynamic intrapreneurial model and to create purposeful brands that push humanity forward. The company creates sustainable novel ingredients, products, and brands that will accelerate the transformation of the industry.

Series B - Debut

Material Impact

Series A - Debut

Grant - Debut

Seed Round - Debut

San Diego

California

United States

North America

The Week’s 10 Biggest Funding Rounds: Nirvana Insurance, Nucleus RadioPharma Lead Week With No Big Rounds

Makeup Unicorn Oddity’s IPO Comes As Beauty Funding Falters

Debut and DIC Corporation Establish Strategic Partnership for Sustainable Production of Multiple Novel High-Performing Active Ingredients for the Beauty Industry

Debut Biotech is creating next-gen ingredients through ‘cell-free biomanufacturing’

Debut Biotech Raises $22.6M in Series A Funding

Debut Biotech makes its entrance with a $22M series A for cell-free biomanufacturing facility

Debut Biotech Partners with Battelle Team to Transform Plastic Waste into High-Value Resources under DARPA’s ReSource Program

DSM Agrees to Evaluate Debut Biotech’s Scalable Cell-Free Manufacturing Platform

Hong Kong

Asia

EnginZyme is a company focused on revolutionizing the chemical industry through sustainable biomanufacturing.

EnginZyme

Ginkgo BioWorks is a company specializing in biotechnology and synthetic biology.

Ginkgo BioWorks

Allozymes is a company focused on developing cosmetic active ingredients through biotechnology.

Allozymes

Letoon Holding is a company involved in the development of sustainable cosmetic ingredients.

Letoon Holding

Michroma is a company specializing in the production of sustainable cosmetic ingredients using biotechnology.

Michroma

CreaGen Inc is a company involved in the development of innovative biotechnology solutions for various industries.

CreaGen Inc

ChemBridge Corp is a company focused on providing chemical research products and services.

ChemBridge Corp

Circle Pharma Inc is a company specializing in the development of macrocycle drugs using biotechnology.

Circle Pharma Inc

NJ Biopharmaceuticals LLC is a company involved in the development of biopharmaceutical products.

NJ Biopharmaceuticals LLC

Debut Biotech is a biotechnology company that harnesses nature, science, and creativity to develop sustainable beauty products and cosmetic active ingredients through breakthrough technology and human-centered brand innovation.

news impact assignment basic	general	Apr 30, 2024 6:39 PM	50b2116c
public peers	general	Apr 30, 2024 6:39 PM	6b7307d1
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Apr 30, 2024 6:39 PM	85e4f289
company summary	general
signals	general
crunchbase trigger	general	Oct 29, 2024 5:10 PM	4d43461f
crunchbase profile	general	Oct 30, 2024 6:45 AM	c954f2cd
li profile	general	Apr 30, 2024 6:39 PM	2b94e20d
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	cb3cbd4e
peers	general
news basic	general	Apr 30, 2024 6:39 PM	68f021f0
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:DEBUTBIOTECH

Debut Biotech